Home » Topics » Medical technology

Medical technology
RSS

Teva Establishing Biotech Fund As Growth Continues In Israel

Feb. 21, 2001

Panel Urges Wider Perspective On Market's 'Random Movement'

Feb. 21, 2001

U.S. Patent Disclosures

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

Medarex Partners With Immusol To Develop Antibody Therapies

Feb. 21, 2001

Gilead Plans Regulatory Filings Based On Pivotal Tenofovir Trial

Feb. 21, 2001

Other News To Note

Feb. 21, 2001

Xenova, Cantab Agree To Merge UK Companies Targeting Cancer

Feb. 21, 2001

European Patent Disclosures

Feb. 20, 2001

Advanced Viral Increases Credit Line To $50M To Fund Product R

Feb. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...